Vesicular Stomatitis (VS) Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: V314FE66AC3AEN
Market Monitor Global

Abstracts

Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.

This report contains market size and forecasts of Vesicular Stomatitis (VS) Therapeutics in Global, including the following market information:

Global Vesicular Stomatitis (VS) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vesicular Stomatitis (VS) Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Symptomatic Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vesicular Stomatitis (VS) Therapeutics include Boehringer Ingelheim, Merck & Co, Zoetis, Vedco, Elanco, Ceva Sant? Animale, Vibrac, Vetoquinol and IDEXX Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vesicular Stomatitis (VS) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vesicular Stomatitis (VS) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vesicular Stomatitis (VS) Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Symptomatic Medications
• Vaccination

Global Vesicular Stomatitis (VS) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vesicular Stomatitis (VS) Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies

Global Vesicular Stomatitis (VS) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vesicular Stomatitis (VS) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vesicular Stomatitis (VS) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vesicular Stomatitis (VS) Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boehringer Ingelheim
• Merck & Co
• Zoetis
• Vedco
• Elanco
• Ceva Sant? Animale
• Vibrac
• Vetoquinol
• IDEXX Laboratories
• Covetrus
• Neogen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vesicular Stomatitis (VS) Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vesicular Stomatitis (VS) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VESICULAR STOMATITIS (VS) THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size: 2021 VS 2028
2.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vesicular Stomatitis (VS) Therapeutics Players in Global Market
3.2 Top Global Vesicular Stomatitis (VS) Therapeutics Companies Ranked by Revenue
3.3 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Vesicular Stomatitis (VS) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vesicular Stomatitis (VS) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vesicular Stomatitis (VS) Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Vesicular Stomatitis (VS) Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vesicular Stomatitis (VS) Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vesicular Stomatitis (VS) Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Symptomatic Medications
  4.1.3 Vaccination
4.2 By Type - Global Vesicular Stomatitis (VS) Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vesicular Stomatitis (VS) Therapeutics Market Size, 2021 & 2028
  5.1.2 Veterinary Hospitals
  5.1.3 Veterinary Clinics
  5.1.4 Retail Pharmacies
5.2 By Application - Global Vesicular Stomatitis (VS) Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vesicular Stomatitis (VS) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2028
  6.3.2 US Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.3.3 Canada Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2028
  6.4.2 Germany Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.4.3 France Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.4.5 Italy Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.4.6 Russia Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2028
  6.5.2 China Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.5.3 Japan Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.5.6 India Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.7.3 Israel Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028
  6.7.5 UAE Vesicular Stomatitis (VS) Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Boehringer Ingelheim
  7.1.1 Boehringer Ingelheim Corporate Summary
  7.1.2 Boehringer Ingelheim Business Overview
  7.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.1.4 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Boehringer Ingelheim Key News
7.2 Merck & Co
  7.2.1 Merck & Co Corporate Summary
  7.2.2 Merck & Co Business Overview
  7.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.2.4 Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Merck & Co Key News
7.3 Zoetis
  7.3.1 Zoetis Corporate Summary
  7.3.2 Zoetis Business Overview
  7.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.3.4 Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Zoetis Key News
7.4 Vedco
  7.4.1 Vedco Corporate Summary
  7.4.2 Vedco Business Overview
  7.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.4.4 Vedco Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Vedco Key News
7.5 Elanco
  7.5.1 Elanco Corporate Summary
  7.5.2 Elanco Business Overview
  7.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.5.4 Elanco Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Elanco Key News
7.6 Ceva Sant? Animale
  7.6.1 Ceva Sant? Animale Corporate Summary
  7.6.2 Ceva Sant? Animale Business Overview
  7.6.3 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.6.4 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Ceva Sant? Animale Key News
7.7 Vibrac
  7.7.1 Vibrac Corporate Summary
  7.7.2 Vibrac Business Overview
  7.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.7.4 Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Vibrac Key News
7.8 Vetoquinol
  7.8.1 Vetoquinol Corporate Summary
  7.8.2 Vetoquinol Business Overview
  7.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.8.4 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Vetoquinol Key News
7.9 IDEXX Laboratories
  7.9.1 IDEXX Laboratories Corporate Summary
  7.9.2 IDEXX Laboratories Business Overview
  7.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.9.4 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 IDEXX Laboratories Key News
7.10 Covetrus
  7.10.1 Covetrus Corporate Summary
  7.10.2 Covetrus Business Overview
  7.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.10.4 Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Covetrus Key News
7.11 Neogen
  7.11.1 Neogen Corporate Summary
  7.11.2 Neogen Business Overview
  7.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Major Product Offerings
  7.11.4 Neogen Vesicular Stomatitis (VS) Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Neogen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vesicular Stomatitis (VS) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Vesicular Stomatitis (VS) Therapeutics Market Drivers in Global Market
Table 3. Vesicular Stomatitis (VS) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Vesicular Stomatitis (VS) Therapeutics in Global Market
Table 5. Top Vesicular Stomatitis (VS) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vesicular Stomatitis (VS) Therapeutics Product Type
Table 9. List of Global Tier 1 Vesicular Stomatitis (VS) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vesicular Stomatitis (VS) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vesicular Stomatitis (VS) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vesicular Stomatitis (VS) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vesicular Stomatitis (VS) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vesicular Stomatitis (VS) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Corporate Summary
Table 31. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 32. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Merck & Co Corporate Summary
Table 34. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 35. Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Zoetis Corporate Summary
Table 37. Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 38. Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Vedco Corporate Summary
Table 40. Vedco Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 41. Vedco Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Elanco Corporate Summary
Table 43. Elanco Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 44. Elanco Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Ceva Sant? Animale Corporate Summary
Table 46. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 47. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Vibrac Corporate Summary
Table 49. Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 50. Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Vetoquinol Corporate Summary
Table 52. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 53. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. IDEXX Laboratories Corporate Summary
Table 55. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 56. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Covetrus Corporate Summary
Table 58. Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 59. Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Neogen Corporate Summary
Table 61. Neogen Vesicular Stomatitis (VS) Therapeutics Product Offerings
Table 62. Neogen Vesicular Stomatitis (VS) Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vesicular Stomatitis (VS) Therapeutics Segment by Type in 2021
Figure 2. Vesicular Stomatitis (VS) Therapeutics Segment by Application in 2021
Figure 3. Global Vesicular Stomatitis (VS) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vesicular Stomatitis (VS) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue in 2021
Figure 8. By Type - Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vesicular Stomatitis (VS) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Vedco Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Elanco Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Neogen Vesicular Stomatitis (VS) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)